2m 2m 2m 2m 2m 2m 2m
Kaya Hldgs (KAYS)
OTC
$0.02-$0.009 (-37.50%)
Price as of Jun 03, 2026- $23.2MMarket Cap
- -54.82%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Kaya Hldgs (KAYS)
$0.02-$0.009 (-37.50%)
KAYS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.01 | ||
Change | +$0.0002 (+0.80%) | ||
Open | $0.02 | ||
High | $0.02 | ||
Low | $0.01 | ||
Previous Close | $0.02 | ||
Volume | 2,684 | ||
30-Day Average Volume | 11,626 | ||
1-Week Change | 179.07% | ||
1-Month Change | -27.93% | ||
1-Year Change | -29.41% | ||
3-Year Change | -54.33% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 686.4M | ||
Total Assets | $199,358.00 | ||
Market Cap | $23.2M | ||
Enterprise Value | $23.7M | ||
Period: QTR TTM FY | |||
Revenue | $5,408.00 | ||
Net Income | -$8.6M | ||
Free Cash Flow | -$67,710.00 | ||
EBIT | -$8.6M | ||
EBITDA | -$8.6M | ||
Net Working Capital | -$2.4M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | 4,382 | ||
P/B | -42 | ||
P/E | -1 | ||
PEG | N/A | ||
Price/Free Cash Flow | -343 | ||
Price/Operating Cash Flow | -343 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 12/15/2020 | ||